Psyence Group Inc.
OTC: PSYGF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Jody Aufrichtig
- Headquarters
- Toronto, Canada
- IPO year
- 2022
- Market cap
- $2.0M
- Website
- https://www.psyence.com
Loading PSYGF…
Loading profile data…Frequently asked questions about PSYGF
What does Psyence Group Inc. (PSYGF) do?
Psyence Group Inc. is a biotechnology firm operating in the life sciences sector, primarily focused on the commercial cultivation and production of psilocybin mushrooms. The company's naturally derived psilocybin is intended for therapeutic applications, targeting a variety of mental health conditions and other medical ailments. Currently, Psyen...
Where does PSYGF trade?
Psyence Group Inc. (PSYGF) trades on the Other OTC.
What sector is PSYGF in?
Psyence Group Inc. (PSYGF) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Psyence Group Inc.?
Jody Aufrichtig is the chief executive officer of Psyence Group Inc. (PSYGF).
Where is Psyence Group Inc. headquartered?
Psyence Group Inc. is headquartered in Canada.
Does PSYGF pay a dividend?
Psyence Group Inc. (PSYGF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PSYGF go public?
Psyence Group Inc. (PSYGF) completed its initial public offering in 2022.